Linco-spectin Vet. injektionsvæske, opløsning 50+100 mg/ml
Linco-spectin Vet. injektionsvæske, opløsning 50+100 mg/ml
Authorised
- Spectinomycin sulfate tetrahydrate
- Lincomycin hydrochloride
Product identification
Medicine name:
Linco-spectin Vet. 50+100 mg/ml injektionsvæske, opløsning
Linco-spectin Vet. injektionsvæske, opløsning 50+100 mg/ml
Active substance:
- Spectinomycin sulfate tetrahydrate
- Lincomycin hydrochloride
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Spectinomycin sulfate tetrahydrate156.30/milligram(s)1.00millilitre(s)
-
Lincomycin hydrochloride59.50/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF52
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Denmark
Available in:
-
Denmark
Package description:
- Available only in Danish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis Animal Health ApS
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Danish Medicines Agency
Authorisation number:
- 06774
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Danish (, INJEKTIONSVÆSKE, OPLØSNING)
Published on: 4/05/2022
How useful was this page?:
